NR2E3 and liver cancer: Validation of the RNA-Seq analysis revealed that co-expression of p53R172H further suppressed protein expression of NR2E3, which emerged as a potential tumor suppressor in breast and liver cancer [50, 51] (Supplementary Fig. S3d).